Estatísticas para NT 2468 2021 - antiangiogênico Orzudex - retinopatia diabética - NATJUS TJMG
Total de visitas
| views | |
|---|---|
| NT 2468 2021 - antiangiogênico Orzudex - retinopatia diabética - NATJUS TJMG | 3 |
Total visitas por mês
| views | |
|---|---|
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
Visitas Arquivos
| views | |
|---|---|
| NT 2021.2468 - EMD Orzudex (1).pdf | 33 |